Related by context. All words. (Click for frequent words.) 79 CD# antibody [001] 77 PEGylated Fab fragment 76 CD# monoclonal antibody 75 CD3 monoclonal antibody 74 investigational humanized monoclonal antibody 74 targeting CD# 74 proteasome inhibitor 74 liposomal formulation 74 humanized monoclonal 74 sodium glucose cotransporter 73 stable nucleic acid 73 targeted antifolate 73 pan HDAC inhibitor 72 humanized antibody 72 PNP inhibitor 72 humanized monoclonal antibody 72 PKC# 72 Fc fusion protein 72 polymerase inhibitor 72 oral prodrug 72 JAK1 72 Milatuzumab 72 selective antagonist 72 Luteinizing Hormone Releasing Hormone 71 hypoxia inducible factor 71 FOLOTYN ® 71 sunitinib Sutent ® 71 Omacetaxine 71 orally administered inhibitor 71 non nucleoside inhibitor 71 peripherally acting 71 TLR9 agonist 71 PDE4 inhibitor 71 imatinib Gleevec ® 71 peptidic compound 71 cetuximab Erbitux R 71 mertansine 71 Factor VIIa 70 orally bioavailable 70 familial amyloidotic polyneuropathy FAP 70 receptor tyrosine kinase inhibitor 70 MEK inhibitor 70 dasatinib Sprycel ® 70 anti CD# antibody 70 CDK inhibitor 70 Pralatrexate 70 AEG# 70 soluble tumor necrosis 70 selective modulator 70 PI3K/Akt pathway inhibitor 70 Aurora kinase 70 bevacizumab Avastin R 70 antibody MAb 70 Bezielle 70 antisense oligonucleotide 70 PEGylated anti 70 Ofatumumab 70 Bortezomib 70 TRX1 70 Epratuzumab 70 histone deacetylase inhibitor 70 Traficet EN 70 MT# MEDI 70 HSP# inhibitor 69 somatostatin analogue 69 Dapagliflozin 69 Factor Receptor 69 Blinatumomab 69 ADP receptor antagonist 69 mu opioid receptor antagonist 69 selective immunoproteasome inhibitor 69 synthetic peptide 69 vapreotide acetate 69 CD4 monoclonal antibody 69 intranasal formulation 69 MTP inhibitor 69 YONDELIS 69 histone deacetylase HDAC inhibitor 69 erlotinib Tarceva ® 69 bevacizumab Avastin ® 69 peptibody 69 sapropterin dihydrochloride 69 depsipeptide 69 DiLA2 69 Sym# 69 investigational pan BCR 69 ENMD # 69 Voreloxin 69 IMiD 69 HCV protease inhibitor 69 Vidofludimus 69 AAG geldanamycin analog 69 chimeric monoclonal antibody 69 XL# XL# 69 CYC# 69 PDX pralatrexate 69 accumulate preferentially 69 ErbB3 69 targeted radiotherapeutic 69 JAK inhibitor 69 Personalized Immunotherapy 69 TNF Tumor Necrosis Factor 69 bispecific 69 Ridaforolimus 69 Factor VEGF 69 Panzem R 69 JAK2 inhibitor 68 IAP inhibitors 68 selective inhibitor 68 highly selective inhibitor 68 nucleoside analog 68 cell lymphoma CTCL 68 methylnaltrexone bromide 68 immunotherapeutic agent 68 ALN TTR 68 cilengitide 68 GRNVAC1 68 selective inhibition 68 Sapacitabine 68 antibody fragment 68 N acetylgalactosamine 6 68 Methylnaltrexone 68 Vascular Endothelial Growth 68 FGFR 68 mitogen activated ERK kinase 68 Gleevec resistant 68 Liposomal 68 drug conjugate 68 cyclin dependent kinase inhibitor 68 VitiGam 68 selective kinase inhibitor 68 generation purine nucleoside 68 selective agonist 68 Intravenous Human 68 radiation sensitizer 68 subcutaneously administered 68 Elvitegravir 68 novel histone deacetylase 68 topoisomerase II inhibitor 68 Davunetide 68 small molecule thrombopoietin 68 ATL# [001] 68 BiTE R 68 intravesical instillation 68 vinca alkaloid 68 vidofludimus 68 Onalta 68 docetaxel Taxotere ® 68 antisense drug 68 PEGylated 68 PI3K inhibitor 68 anti CD3 68 cetuximab Erbitux ® 68 huC# DM4 68 cathepsin K inhibitor 68 IAP inhibitor 68 CYT# potent vascular disrupting 68 tyrosine kinase inhibitor 68 Tesetaxel 68 nicotinic alpha 7 68 Virulizin ® 68 refractory chronic lymphocytic 68 oral proteasome inhibitor 68 DNA intercalator 68 Thiarabine 68 cancer immunotherapies 68 platinum chemotherapeutic 68 CEQ# 68 Presents Preclinical Data 68 mTOR mammalian target 68 Chemokine Receptor 68 taxane derivative 68 anticancer agent 68 adecatumumab MT# 68 PEG SN# 68 Romidepsin 68 luteinizing hormone releasing 68 pralatrexate injection folate analogue 68 Omacetaxine mepesuccinate 68 protein tyrosine phosphatase 1B 68 ALN TTR# 68 BiTE ® 68 Phase #b/#a clinical 68 effector function 68 hypereosinophilic syndrome 68 IgG1 monoclonal antibody 68 HuMax CD4 68 NS#/#A protease 68 MAGE A3 ASCI 68 Tezampanel 68 lipid nanoparticle 68 Xanafide 67 pathophysiological effects 67 nucleotide analog 67 small molecule agonists 67 PARI Pharma GmbH 67 immunostimulatory 67 agonistic human 67 delivered RNAi therapeutic 67 prodrug 67 p# mitogen activated 67 5 HT6 67 R bendamustine hydrochloride 67 small molecule chemotherapeutic 67 Lenocta 67 ABL inhibitor 67 Alfacell proprietary ribonuclease 67 octreotide implant 67 Anticalin R 67 Novel Oral 67 immunotherapeutic 67 antibody MT# 67 HuLuc# 67 tiapamil 67 anti CD# monoclonal 67 novel peptide 67 Aflibercept 67 novel topoisomerase 67 small molecule glucokinase 67 ALN PCS 67 Hypoxia Inducible Factor 67 Preclinical studies suggest 67 MT#/MEDI-# 67 IL #E 67 Serostim R 67 androgen receptor AR 67 Azacitidine 67 polymerase inhibitors 67 2 methoxyestradiol 67 selective adenosine 67 Phase Ib clinical trials 67 pegylated 67 hormone LHRH antagonist 67 AKT inhibitor 67 poly ADP ribose polymerase 67 MyVax R 67 long acting muscarinic 67 Recombinant Human 67 virus HCV protease inhibitor 67 MKC# MKC# PP 67 volociximab 67 factor G CSF 67 RECOTHROM R 67 Monoclonal Antibody 67 NXL# 67 thalidomide Thalomid 67 Solazed TM 67 Bosutinib 67 adenoviral 67 BiTE antibody 67 IL# PE#QQR 67 interleukin IL -# 67 GW# [003] 67 Fludara ® 67 SGLT2 67 Chinese Hamster Ovary 67 Janus kinase 67 IMA# 67 drug pipeline TAFA# 67 novel immunomodulatory 67 inhibitor RG# 67 Liprotamase 67 milatuzumab 67 R roscovitine CDK cyclin 67 Ozarelix 67 HCD# [002] 67 phase IIb clinical 67 Pharmacokinetics PK 67 partial agonist 67 antisense inhibitors 67 Tumor Necrosis Factor 67 renin inhibitor 67 immunomodulator 67 monoclonal 67 Dasatinib 67 Azedra 67 EGF receptor 67 FLT3 67 Bucindolol 67 Romiplostim 67 essential thrombocythemia ET 67 Epothilones 67 Nexavar ® 67 phosphate S1P 67 Epidermal Growth Factor Receptor 67 novel VDA molecule 67 modulator SERM 67 GTC recombinant human 67 Trastuzumab 67 HQK 67 NPC 1C 67 EZN 67 epothilones 67 Radiation Therapy SIRT 67 hA# 67 CD# expressing 67 Familial Adenomatous Polyposis FAP 67 Uricase PEG 67 myelofibrosis polycythemia vera 67 BCR ABL inhibitors 67 PTH analogue 67 adenosine A2A 67 investigational monoclonal antibody 67 vascular disrupting agents 67 Humanized Anti 67 octreotide acetate 67 humanized antibodies 67 immune modulatory 67 rusalatide acetate 67 HGS ETR2 67 CCX# 67 LymphoStat B belimumab 67 Guanilib 66 developing Bicifadine serotonin 66 MKC# MT 66 Aliskiren 66 BiTE 66 diarrhea predominant irritable 66 replicon 66 PSMA ADC 66 receptor agonist 66 synthetic siRNA 66 immune modulator 66 monoclonal antibody mAb 66 Tumour Vascular Disrupting Agent 66 hyaluronidase enzyme 66 epratuzumab 66 DOS# 66 Hsp# Inhibitor 66 DURECT proprietary 66 Carfilzomib 66 Homspera TM 66 Daclizumab 66 hypoxia activated prodrug 66 PRTX 66 relapsed multiple myeloma 66 selective orally bioavailable 66 chronic eosinophilic leukemia 66 immunomodulating 66 Orally administered 66 RhuDex ® 66 Myolimus 66 uricase 66 M2 subunit 66 colon carcinoma 66 beta 1a 66 Zorbtive TM 66 imatinib Gleevec 66 proteasome inhibitors 66 T#I [002] 66 peripheral blood mononuclear 66 hormone agonist 66 Aplidin R 66 multi kinase inhibitor 66 product platforms AZX# 66 thymalfasin 66 sphingosine 1 66 dasatinib Sprycel 66 MMAE 66 Squalamine 66 BAY #-# 66 oral dihydropyrimidine dehydrogenase DPD 66 TAFA# 66 vWF 66 TLR9 agonists 66 isoform selective 66 VEGF receptor 66 Quinamed 66 immunoconjugate 66 PRT# 66 Clolar ® 66 angiogenesis inhibitor 66 XmAb# 66 tyrosine kinase receptor 66 potent CYP#A# inhibitors 66 Platelet Derived Growth 66 Kinase Inhibitor 66 Lenalidomide 66 Lubiprostone 66 molecular imaging radiopharmaceutical 66 small molecule Hedgehog 66 Degarelix 66 Dalbavancin 66 CCR5 antagonist 66 allosteric modulator NAM 66 TKB# 66 paclitaxel Taxol ® 66 kinase inhibitor 66 Annamycin 66 Hedgehog pathway inhibitor 66 systemic RNAi therapeutic 66 IMiDs R 66 HCV protease 66 5HT 66 mGluR5 negative 66 proprietary polysaccharide 66 Cytochrome P# 66 ISF# 66 Pazopanib 66 Pertuzumab 66 alvespimycin 66 MAXY G# 66 XL# anticancer compounds 66 Phase 2b Clinical Trial 66 rHuPH# recombinant human 66 EGFr 66 Interferon alpha 66 pertuzumab 66 SAR# [002] 66 Elotuzumab 66 Alocrest 66 Peginterferon alfa 2b 66 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 66 Protein Kinase C 66 PEGylated interferon 66 polyclonal antibody 66 HGS# 66 recombinant adeno associated 66 ArQule Kinase Inhibitor Platform 66 5 HT3 antagonist 66 Panzem R NCD 66 docetaxel Taxotere R 66 castrate resistant prostate cancer 66 Ceflatonin 66 Granulocyte Colony Stimulating Factor 66 HGS ETR1 66 Enzyme Replacement Therapy 66 Curaxin CBLC# 66 fosbretabulin 66 EpCAM 66 KSP inhibitor 66 BAL# [001] 66 mRNA antagonists 66 Aurora Kinase 66 IMiDs ® compound 66 ARRY # 66 opioid receptor antagonist 66 C1INH 66 lexidronam injection 66 reversible inhibitor 66 vinorelbine tartrate 66 metaglidasen 66 selectively inhibited 66 Pathway Inhibitor 66 5 HT3 receptor 66 vascular disrupting agent 66 alpha folate receptor 66 Zevalin R Ibritumomab 65 XYOTAX TM 65 JAK inhibitors 65 L asparaginase 65 TELINTRA 65 Drug Candidate 65 potent inhibitor 65 Proxinium TM 65 samarium Sm 65 pan histone deacetylase 65 Seliciclib 65 inhaled formulation 65 R Saizen R 65 chemokine receptor 65 adult mesenchymal stem 65 Irinotecan 65 Tyrima 65 tyrosine kinase inhibitor TKI 65 Solazed ™ 65 colony stimulating factor 65 liposomal delivery 65 Pradefovir 65 CDK cyclin dependent 65 Inhalation Aerosol 65 Ceflatonin R 65 eniluracil 65 OMP #M# 65 Safinamide 65 demonstrated antitumor activity 65 alkylating agent 65 CCX# B 65 TRAIL R2 65 Silodosin 65 Temsirolimus 65 Bendamustine 65 vinca alkaloids 65 histone deacetylase HDAC 65 systemically administered 65 CR# vcMMAE 65 Denufosol 65 Monoclonal antibody 65 highly selective endothelin 65 ABLYNX 65 generation Hsp# inhibitor 65 imatinib mesylate 65 Myocet 65 tafamidis 65 forodesine 65 ketolide antibiotic 65 antisense inhibitor 65 Locked Nucleic Acid 65 Abiraterone acetate 65 Nanobody 65 EGFR HER2 65 Talabostat 65 #D#C# 65 Kit CD# positive 65 oral Janus kinase 65 non nucleoside 65 chemically modified siRNA 65 Anticalin ® 65 small molecule defensin 65 DermaVir Patch 65 Apoptone 65 novel orally administered 65 alfa 2a 65 5 HT6 receptor 65 trastuzumab Herceptin R 65 antisense oligonucleotides 65 brand ciclesonide HFA 65 human monoclonal antibody 65 mTOR inhibitor 65 Ixabepilone 65 Antigen Specific 65 Eculizumab 65 RAV# 65 potent topoisomerase II 65 sorafenib Nexavar 65 LNP formulations 65 Copegus ® 65 POTELLIGENT ® 65 NS4A 65 Symadex 65 Amrubicin 65 5 Fluorouracil 65 entinostat 65 thrombin receptor 65 fumarate 65 HCV NS3 protease 65 protein kinase inhibitor 65 investigational pharmacologically unique 65 anti CD# antibodies 65 active metabolite 65 castration resistant prostate cancer 65 VAPRISOL 65 metastatic malignant 65 orally dosed 65 Angiotensin Converting Enzyme 65 Elagolix 65 macrophage colony stimulating 65 Meets Primary Endpoint 65 Enkephalin 65 polysaccharide polymer 65 Ocrelizumab 65 Transdrug ® nanoparticle 65 extracellular domain 65 direct thrombin inhibitor 65 dependent kinase inhibitor 65 MDRNA proprietary 65 arsenic trioxide injection 65 immunotoxins 65 irreversible inhibitor 65 AtuRNAi 65 nilotinib Tasigna 65 2 inhibitor CYT# 65 OXi# 65 bispecific antibody 65 dihydrochloride 65 IFN alpha 65 Linaclotide 65 humanized monoclonal antibodies 65 novel synthetic peptide 65 oral ghrelin agonist 65 leukemia CLL 65 prodrugs 65 topical gel formulation 65 SinuNase TM 65 imatinib resistant 65 sipuleucel T 65 Ecallantide 65 MGd 65 Tarvacin TM 65 BENLYSTA ® 65 MEK inhibitors 65 busulfan 65 CCR9 antagonist 65 small molecule inhibitor 65 Bavituximab 65 Anticalins R 65 candidate deforolimus 65 Locked Nucleic Acid LNA 65 RNAi therapeutic targeting 65 oncolytic virus therapies 65 XmAb ™ 65 receptor inhibitor 65 Decitabine 65 Initiates Phase II 65 urate oxidase 65 SIRT2 65 siRNA therapeutic 65 leukemia AML 65 ribonuclease 65 NS5b 65 PXD# 65 IMiDs ® 65 OncoVEX 65 TKM ApoB 65 peripherally restricted 65 posaconazole 65 ATRA IV 65 TREANDA 65 Neulasta ® 65 INCB# [001] 65 Immunotherapeutic 65 pharmacological chaperone 65 antiangiogenic 65 HuCAL GOLD R 65 oral nucleoside analogue 65 Genasense ® 65 JAK2 V#F 65 AzaSite Xtra 65 Imatinib mesylate 65 XL# inhibits 65 Cathepsin S 65 Deforolimus 65 ZEVALIN ® 65 ara C 65 bortezomib Velcade 65 trastuzumab DM1 T DM1 65 Xencor XmAb 65 oral beclomethasone dipropionate 65 induces apoptosis 65 veltuzumab 65 LHRH antagonist 65 Enzastaurin 65 Micromet BiTE 65 multiple myeloma MM 65 3 kinase PI3K 65 anionic backbone 65 GMX# 65 therapeutic monoclonal antibody 65 Phase 2a Clinical Trial 65 Mipomersen 65 oral JAK#/JAK# inhibitor 65 PSMA antibody 65 injectable formulation 65 Plicera 65 orally bioavailable mimics 65 acyclovir Lauriad ® 65 BCR ABL inhibitor 65 Preclinical Data 65 AMPA kainate 65 Albuferon TM 65 Cleviprex TM clevidipine 65 aurora kinase 65 apoptosis proteins 65 enzyme inhibitor 65 HGS ETR1 mapatumumab 65 daptomycin 65 Glufosfamide 65 Oracea TM 65 siRNA binds 65 Lixivaptan 65 TO AVOID PREGNANCY WHILE 65 ocular formulation 65 PD LID 65 biomodulator 65 LymphoStat B TM 65 Phase IIb Trial 65 II Clinical Trial 65 Tumor necrosis factor 65 therapeutic monoclonal antibodies 65 monoclonal anti 65 interferon IFN 65 Pemetrexed 65 AKIP ™ 65 HER1 64 VEGFR2 inhibitor 64 MAb 64 Maxy G# 64 Fibroblast Growth Factor Receptor 64 cell mediated cytotoxicity 64 Phase IIb Clinical Trial 64 OHR/AVR# 64 OMP #R# 64 Pimavanserin 64 Civacir 64 Thrombin topical Recombinant 64 Macrophage 64 CYP#A# CYP#D# 64 mGluR2 positive 64 Parkinson disease levodopa induced 64 tkRNAi 64 evaluating tivozanib 64 Calcitonin 64 ARIKACE 64 Parathyroid Hormone 64 generation antisense inhibitor 64 nucleoside 64 vesicular monoamine transporter 64 HDAC Inhibitor 64 iobenguane 64 alpha interferon 64 LEX System 64 anti angiogenic agent 64 immunotoxin 64 nicotinic acetylcholine receptor 64 acetonide FA 64 CRTH2 64 mGluR2 NAM 64 REMUNE R 64 receptor partial agonist 64 PPARgamma 64 cysteamine bitartrate 64 Anidulafungin 64 Payload TAP technology 64 selective androgen receptor modulator 64 cleavable linker 64 itraconazole Sporanox 64 Disease IBD 64 immunomodulatory 64 Cloretazine 64 Archexin 64 chemotherapeutic agent 64 Kuvan R 64 LPA1 receptor 64 alpha#beta# integrin 64 ceftazidime 64 delta opioid receptor 64 Mucosal 64 antitumoral 64 Maribavir 64 Initiates Clinical 64 NS5B polymerase 64 TLK# 64 multikinase inhibitor 64 Initiates Clinical Trial 64 Ampligen ® 64 Kahalalide F 64 Microplasmin 64 EOquin 64 p# inhibitor 64 anti CD3 monoclonal 64 SAR# [004] 64 Unit Dose Budesonide 64 BCR ABL 64 rxRNA 64 5alpha reductase 64 Aurora kinase inhibitor 64 SGLT2 inhibitor 64 IgG1 antibody 64 coronary vasodilation 64 HDACi 64 Otelixizumab 64 Advanced Renal Cell 64 lintuzumab SGN 64 Atripla combines 64 Elesclomol 64 DUROS 64 Sphingomab TM 64 lipid particles 64 MYDICAR ® 64 vitro cytotoxicity 64 small molecule activator 64 Selective Inhibitor 64 Etoposide 64 CIMZIA R 64 Tesamorelin 64 Initiate Phase 64 antifibrotic 64 mGluR5 NAM 64 MGCD# [001] 64 syngeneic 64 metastatic castration resistant 64 intravenously administered 64 alkylating 64 Campath ® 64 relapsing multiple sclerosis 64 R#/MEM # 64 TG# [003] 64 peptidomimetic 64 Soriatane R 64 Janus Kinase 64 Initiate Clinical Trial 64 interferon beta 1a infertility 64 OMNARIS HFA 64 Anti Tumor 64 MAP# 64 rNAPc2 64 Marqibo TM 64 Perifosine 64 oral Hsp# inhibitor 64 Everolimus 64 otelixizumab 64 reversible inhibitors 64 interferon alfa 64 ALK inhibitor 64 novel synthetic PEGylated 64 Xyfid TM 64 TRAIL receptor 64 hepatoma 64 tumor specific antigen 64 binds selectively 64 Kuvan sapropterin dihydrochloride 64 synthetic retinoid 64 mapatumumab 64 ELACYT 64 Prodrug 64 Antiviral Activity 64 CD# CD# 64 5 FU leucovorin 64 TTR gene 64 CTAP# Capsules 64 ALVESCO ® 64 JAK2 Inhibitor 64 selectively inhibits 64 G Protein Coupled 64 CD# CEA 64 Acute Myeloid Leukemia AML 64 alpha 2b 64 meropenem 64 allogeneic cell 64 somatropin Kuvan R 64 Belimumab 64 Onconase 64 Copegus ribavirin 64 relapsed refractory multiple myeloma 64 Eg5 64 dextromethorphan quinidine 64 KRN# 64 Vidaza azacitidine 64 lipoglycopeptide 64 tumor xenograft models 64 A3 adenosine receptor 64 liposome encapsulated 64 small molecule inhibitors 64 investigational immunotherapy 64 BYETTA ® 64 inhibitor PPI 64 Neupogen ® 64 elotuzumab 64 Radezolid 64 Metastatic Melanoma 64 Fleximer 64 Polymerase Inhibitor 64 Study Evaluating 64 thymidylate synthase TS 64 goserelin 64 CBLC# 64 MORAb 64 investigational compounds 64 anti CD3 antibody 64 erythropoietin receptor 64 GVAX ® 64 Randomized Phase 64 oral ridaforolimus 64 Rituximab 64 monoclonal antibody 64 IgG1 64 Phase 2a clinical 64 Navelbine ® 64 alpha antagonist 64 novel antibody therapeutics 64 TNF alpha selectively neutralizing 64 subcutaneous formulation 64 Ovitrelle R Serostim 64 Palonosetron 64 SARMs 64 murine monoclonal antibody 64 cutaneous T 64 Atrasentan 64 AEGR 64 Antiangiogenic 64 Laquinimod 64 product candidate Lpathomab 64 Darinaparsin 64 cytotoxin 64 refractory gout 64 TACI Ig 64 Tyrosine Kinase Inhibitor 64 exon skipping 64 Xeloda ® 64 Sphingosine 1 64 formerly LymphoStat B 64 ANYARA 64 compound AEZS 64 Inhalation Solution 64 class anticancer quinolone 64 granulocyte colony stimulating 64 RECOTHROM ® 64 RON Notch 64 Phase Ib study 64 Oncolytic 64 IV Busulfex 64 Imprime PGG 64 GTC recombinant form 64 SGLT2 inhibitors 64 XmAb 64 kidney urologic 64 plasma kallikrein inhibitor 64 polycythemia vera PV 64 R#/MEM 64 HCV RNA polymerase 64 Interferon alfa 64 P#X# antagonist 64 INSPIRE Trial Phase III 64 N methyl 64 indinavir Crixivan 64 phase IIa clinical 64 Cetrorelix 64 recombinant subunit vaccine 64 hormone LHRH 64 lanreotide 64 ERK1 2 64 FDA APPROVES 64 GSK # 64 Litx 64 denileukin diftitox 64 permeation enhancer 64 signal transduction inhibitor 64 product Fentanyl TAIFUN 64 candidates Azedra 64 armodafinil Tablets C 64 recombinant fusion 64 tigecycline 64 compound PMX # 64 maturation inhibitor 64 survivin 64 Delipidation 64 B lymphocyte stimulator 64 ISTODAX 64 metastatic neuroendocrine tumors 64 Receives Orphan Drug Designation 64 Ranolazine 64 huN# DM1 64 oxidative stress inducer 64 Chemophase 64 methionine aminopeptidase 64 PDE4 64 HuMax HepC TM 64 VEGF receptors 64 Microspheres 64 Receptors GPCRs 64 dipeptidyl peptidase IV 64 ESBA# 64 telomerase therapeutic 64 derivatives Radilex TM 64 targets Galectin receptors 64 Pegasys ® 64 camptothecin 64 immunomodulatory therapy 64 Thiovir 64 Cimzia certolizumab pegol 64 acyclovir Lauriad R 63 atacicept 63 TBC# 63 biologic therapy 63 VISICOL R 63 tubulin binding 63 delta isoform 63 Leukine ® 63 amrubicin 63 HuMax 63 GAMMAGARD 63 R sorafenib tablets 63 FK# 63 Tamibarotene 63 echinocandin 63 Adenosine A2A 63 ALN HPN 63 bispecific antibodies 63 vivo validation 63 c MET 63 Vascugel 63 HCV replicon 63 ErbB1 63 LEUKINE 63 REP# 63 positive allosteric modulator 63 Preclinical Study 63 Mg Usa 63 BCG refractory carcinoma 63 AQ4N 63 anticancer therapeutics 63 trabectedin 63 Pyridorin TM 63 ribavirin Copegus ® 63 gonadotropin releasing hormone GnRH 63 sorafenib tablets 63 BIM #A# 63 CTLA 4 63 anti amnesic 63 SPRYCEL ® 63 immunomodulators 63 INCB# [003] 63 nalbuphine ER 63 erythropoiesis stimulating agent 63 GSK '# 63 Debio 63 5 HT4 63 novel prodrug 63 Aviptadil